印度制药公司因质量问题从美国召回了13 700多瓶酒和25种产品。 Indian drug firms recall over 13,700 bottles and 25 products from the U.S. due to quality issues.

印度制药公司Glennmark、Sun Pharma和Zydus因制造和质量问题从美国市场上召回药品。 Indian pharmaceutical companies Glenmark, Sun Pharma, and Zydus are recalling drugs from the US market due to manufacturing and quality issues. Glenmark指出,由于制造业做法不良,超过25种产品被召回;Sun Pharma则因污染而召回13 700瓶加巴潘廷,Zydus则因杂质而召回氯promazine片。 Glenmark is recalling over 25 products due to poor manufacturing practices, Sun Pharma is recalling 13,700 bottles of Gabapentin due to contamination, and Zydus is recalling Chlorpromazine tablets due to impurities. 这些召回被归类为对暂时健康构成的风险最小到极小。 These recalls are categorized as posing minimal to temporary health risks.